| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.796 | 0.003 | 0.796 | Alcohol oxidase inhibitor | 0.078 0.025 CID_154699659 | ||
| 0.763 | 0.005 | 0.763 | Aldehyde oxidase inhibitor | |||
| 0.758 | 0.002 | 0.758 | Peroxidase inhibitor | 0.2 0.059 CID_154699659 | ||
| 0.725 | 0.004 | 0.786 | Histamine release inhibitor | 0.786 0.004 CID_154699659 | CID_154699659 | |
| 0.734 | 0.02 | 0.734 | Caspase 9 stimulant | 0.708 0.023 CID_154699659 | ||
| 0.716 | 0.007 | 0.843 | Cholesterol antagonist | 0.843 0.003 CID_154699659 | CID_154699659 | |
| 0.675 | 0.008 | 0.675 | Vasodilator, peripheral | 0.64 0.011 CID_154699659 | ||
| 0.652 | 0.004 | 0.652 | GABA C receptor rho-3 antagonist | |||
| 0.651 | 0.004 | 0.651 | Anesthetic general | 0.616 0.004 CID_154699659 | ||
| 0.616 | 0.009 | 0.634 | 5 Hydroxytryptamine release inhibitor | 0.634 0.007 CID_154699659 | CID_154699659 | |
| 0.592 | 0.014 | 0.661 | Spasmolytic | 0.661 0.008 CID_154699659 | CID_154699659 | |
| 0.576 | 0.009 | 0.576 | Calcium channel L-type activator | 0.364 0.107 CID_154699659 | ||
| 0.523 | 0.01 | 0.546 | Vasodilator | 0.546 0.009 CID_154699659 | CID_154699659 | |
| 0.545 | 0.038 | 0.79 | Transcription factor NF kappa B inhibitor | 0.79 0.013 CID_154699659 | CID_154699659 | |
| 0.507 | 0.004 | 0.507 | Anesthetic local | |||
| 0.511 | 0.014 | 0.715 | Vasodilator, coronary | 0.715 0.004 CID_154699659 | CID_154699659 | |
| 0.501 | 0.005 | 0.665 | Alpha-N-acetylglucosaminidase inhibitor | 0.665 0.003 CID_154699659 | CID_154699659 | |
| 0.516 | 0.037 | 0.516 | 15-Lipoxygenase inhibitor | |||
| 0.482 | 0.021 | 0.482 | Lipoxygenase inhibitor | |||
| 0.454 | 0.003 | 0.454 | Succinate dehydrogenase inhibitor | 0.216 0.037 CID_154699659 | ||
| 0.457 | 0.008 | 0.457 | Phospholipase C inhibitor | 0.35 0.014 CID_154699659 | ||
| 0.48 | 0.032 | 0.826 | Antithrombotic | 0.826 0.004 CID_154699659 | CID_154699659 | |
| 0.477 | 0.031 | 0.477 | 5 Hydroxytryptamine release stimulant | 0.394 0.047 CID_154699659 | ||
| 0.462 | 0.017 | 0.462 | Superoxide dismutase inhibitor | |||
| 0.446 | 0.005 | 0.446 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.442 | 0.013 | 0.442 | Calcium channel activator | |||
| 0.426 | 0.005 | 0.426 | Aldehyde dehydrogenase inhibitor | 0.342 0.008 CID_154699659 | ||
| 0.433 | 0.012 | 0.576 | Cyclic AMP phosphodiesterase inhibitor | 0.576 0.004 CID_154699659 | CID_154699659 | |
| 0.427 | 0.01 | 0.427 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.417 | 0.011 | 0.665 | Monophenol monooxygenase inhibitor | 0.665 0.004 CID_154699659 | CID_154699659 | |
| 0.431 | 0.032 | 0.431 | 12-Lipoxygenase inhibitor | |||
| 0.4 | 0.012 | 0.577 | Melanin inhibitor | 0.577 0.004 CID_154699659 | CID_154699659 | |
| 0.392 | 0.004 | 0.392 | Carbonic anhydrase XV inhibitor | |||
| 0.387 | 0.003 | 0.387 | Keratolytic | 0.078 0.051 CID_154699659 | ||
| 0.375 | 0.011 | 0.707 | Amylase inhibitor | 0.707 0.003 CID_154699659 | CID_154699659 | |
| 0.453 | 0.095 | 0.692 | Alpha-glucosidase inhibitor | 0.692 0.035 CID_154699659 | CID_154699659 | |
| 0.386 | 0.037 | 0.661 | Antioxidant | 0.661 0.008 CID_154699659 | CID_154699659 | |
| 0.351 | 0.003 | 0.351 | Creatine kinase inhibitor | 0.086 0.078 CID_154699659 | ||
| 0.348 | 0.005 | 0.682 | Cyclooxygenase 3 inhibitor | 0.682 0.002 CID_154699659 | CID_154699659 | |
| 0.347 | 0.004 | 0.347 | Macrophage migration inhibitory factor inhibitor | |||
| 0.376 | 0.033 | 0.593 | Free radical scavenger | 0.593 0.009 CID_154699659 | CID_154699659 | |
| 0.344 | 0.004 | 0.344 | Toll-Like receptor 2 antagonist | 0.179 0.035 CID_154699659 | ||
| 0.366 | 0.03 | 0.366 | Sodium/bile acid cotransporter inhibitor | 0.289 0.089 CID_154699659 | ||
| 0.353 | 0.019 | 0.586 | Non-steroidal antiinflammatory agent | 0.586 0.005 CID_154699659 | CID_154699659 | |
| 0.395 | 0.064 | 0.395 | Calpain 2 inhibitor | |||
| 0.358 | 0.029 | 0.358 | Sigma receptor agonist | |||
| 0.342 | 0.014 | 0.342 | Lipocortins synthesis antagonist | 0.261 0.03 CID_154699659 | ||
| 0.33 | 0.01 | 0.33 | Phospholipase A2 inhibitor | 0.254 0.022 CID_154699659 | ||
| 0.322 | 0.006 | 0.616 | Mediator release inhibitor | 0.616 0.004 CID_154699659 | CID_154699659 | |
| 0.346 | 0.03 | 0.489 | Interleukin agonist | 0.489 0.009 CID_154699659 | CID_154699659 | |
| 0.318 | 0.006 | 0.318 | Adenylate kinase inhibitor | 0.241 0.011 CID_154699659 | ||
| 0.341 | 0.033 | 0.35 | Psychostimulant | 0.35 0.032 CID_154699659 | CID_154699659 | |
| 0.304 | 0.004 | 0.414 | Photosensitizer | 0.414 0.003 CID_154699659 | CID_154699659 | |
| 0.303 | 0.003 | 0.303 | Ornithine decarboxylase inhibitor | 0.192 0.005 CID_154699659 | ||
| 0.304 | 0.005 | 0.304 | GABA C receptor rho-2 antagonist | |||
| 0.359 | 0.062 | 0.597 | Immunostimulant | 0.597 0.017 CID_154699659 | CID_154699659 | |
| 0.302 | 0.006 | 0.302 | Carbonic anhydrase VI inhibitor | 0.124 0.028 CID_154699659 | ||
| 0.348 | 0.057 | 0.539 | Apoptosis antagonist | 0.539 0.016 CID_154699659 | CID_154699659 | |
| 0.31 | 0.021 | 0.31 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.22 0.058 CID_154699659 | ||
| 0.329 | 0.043 | 0.699 | Hypoglycemic | 0.699 0.005 CID_154699659 | CID_154699659 | |
| 0.287 | 0.005 | 0.287 | TRPA1 agonist | 0.155 0.028 CID_154699659 | ||
| 0.35 | 0.073 | 0.35 | Thyroid hormone antagonist | |||
| 0.288 | 0.011 | 0.443 | UDP-glucose 4-epimerase inhibitor | 0.443 0.004 CID_154699659 | CID_154699659 | |
| 0.354 | 0.081 | 0.354 | Prostaglandin dehydrogenase inhibitor | |||
| 0.319 | 0.048 | 0.319 | Insulysin inhibitor | |||
| 0.276 | 0.009 | 0.348 | Xanthine oxidase inhibitor | 0.348 0.005 CID_154699659 | CID_154699659 | |
| 0.273 | 0.008 | 0.273 | Histidine decarboxylase inhibitor | |||
| 0.273 | 0.007 | 0.273 | Carbonic anhydrase XIII inhibitor | 0.25 0.009 CID_154699659 | ||
| 0.296 | 0.032 | 0.296 | RNA-directed DNA polymerase inhibitor | 0.244 0.053 CID_154699659 | ||
| 0.274 | 0.012 | 0.274 | Cystathionine beta-synthase inhibitor | 0.217 0.021 CID_154699659 | ||
| 0.267 | 0.007 | 0.267 | Porphobilinogen synthase inhibitor | |||
| 0.281 | 0.021 | 0.281 | Insulin sensitizer | 0.258 0.03 CID_154699659 | ||
| 0.293 | 0.038 | 0.293 | Gastrin inhibitor | 0.25 0.079 CID_154699659 | ||
| 0.296 | 0.045 | 0.434 | DNA synthesis inhibitor | 0.434 0.018 CID_154699659 | CID_154699659 | |
| 0.272 | 0.021 | 0.431 | Protein kinase stimulant | 0.431 0.006 CID_154699659 | CID_154699659 | |
| 0.272 | 0.027 | 0.29 | Neurotrophic factor enhancer | 0.29 0.021 CID_154699659 | CID_154699659 | |
| 0.25 | 0.007 | 0.432 | Triose-phosphate isomerase inhibitor | 0.432 0.003 CID_154699659 | CID_154699659 | |
| 0.251 | 0.009 | 0.251 | Carbonic anhydrase III inhibitor | 0.129 0.039 CID_154699659 | ||
| 0.293 | 0.052 | 0.779 | Angiogenesis stimulant | 0.779 0.004 CID_154699659 | CID_154699659 | |
| 0.368 | 0.13 | 0.594 | Apoptosis agonist | 0.594 0.05 CID_154699659 | CID_154699659 | |
| 0.243 | 0.007 | 0.243 | GABA C receptor antagonist | |||
| 0.316 | 0.08 | 0.316 | Thyroid hormone beta antagonist | |||
| 0.248 | 0.013 | 0.248 | Ferrochelatase inhibitor | |||
| 0.366 | 0.131 | 0.366 | DNA directed DNA polymerase inhibitor | |||
| 0.241 | 0.008 | 0.241 | Arachidonic acid antagonist | 0.196 0.037 CID_154699659 | ||
| 0.261 | 0.029 | 0.261 | Amyloid beta precursor protein antagonist | |||
| 0.298 | 0.067 | 0.331 | Hypoxia-inducible factor 1 alpha inhibitor | 0.331 0.052 CID_154699659 | CID_154699659 | |
| 0.258 | 0.027 | 0.397 | Interferon gamma antagonist | 0.397 0.011 CID_154699659 | CID_154699659 | |
| 0.339 | 0.108 | 0.647 | Antibacterial | 0.647 0.013 CID_154699659 | CID_154699659 | |
| 0.254 | 0.026 | 0.363 | Lipid peroxidase inhibitor | 0.363 0.012 CID_154699659 | CID_154699659 | |
| 0.244 | 0.019 | 0.244 | Cholesterol synthesis inhibitor | 0.161 0.039 CID_154699659 | ||
| 0.263 | 0.04 | 0.526 | Hepatoprotectant | 0.526 0.006 CID_154699659 | CID_154699659 | |
| 0.249 | 0.025 | 0.249 | Acetylcholine M1 receptor antagonist | |||
| 0.22 | 0.004 | 0.223 | Glutamate release inhibitor | 0.223 0.004 CID_154699659 | CID_154699659 | |
| 0.279 | 0.064 | 0.279 | Transcription factor STAT3 inhibitor | |||
| 0.219 | 0.005 | 0.219 | Glutamate decarboxylase inhibitor | |||
| 0.258 | 0.044 | 0.324 | DNA methyltransferase I inhibitor | 0.324 0.019 CID_154699659 | CID_154699659 | |
| 0.271 | 0.059 | 0.395 | Hypolipemic | 0.395 0.026 CID_154699659 | CID_154699659 | |
| 0.229 | 0.019 | 0.229 | 5-Lipoxygenase inhibitor | |||
| 0.221 | 0.012 | 0.221 | Catalase inhibitor | |||
| 0.221 | 0.012 | 0.221 | CF transmembrane conductance regulator agonist | 0.169 0.048 CID_154699659 | ||
| 0.21 | 0.003 | 0.21 | Glutamate (mGluR6) antagonist | 0.105 0.009 CID_154699659 | ||
| 0.218 | 0.011 | 0.218 | Estrogen antagonist | 0.102 0.094 CID_154699659 | ||
| 0.211 | 0.005 | 0.211 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.313 | 0.107 | 0.529 | Immunosuppressant | 0.529 0.025 CID_154699659 | CID_154699659 | |
| 0.289 | 0.084 | 0.334 | Caspase 3 stimulant | 0.334 0.064 CID_154699659 | CID_154699659 | |
| 0.218 | 0.017 | 0.514 | Expectorant | 0.514 0.004 CID_154699659 | CID_154699659 | |
| 0.205 | 0.006 | 0.205 | DOPA decarboxylase inhibitor | |||
| 0.207 | 0.007 | 0.207 | GABA C receptor rho-1 antagonist | |||
| 0.208 | 0.012 | 0.208 | Mucolytic | 0.197 0.014 CID_154699659 | ||
| 0.199 | 0.004 | 0.199 | Ca2+-transporting ATPase inhibitor | 0.188 0.005 CID_154699659 | ||
| 0.2 | 0.006 | 0.2 | Heat shock protein 70 antagonist | 0.196 0.007 CID_154699659 | ||
| 0.194 | 0.003 | 0.194 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.249 | 0.061 | 0.249 | Pyruvate kinase inhibitor | |||
| 0.234 | 0.047 | 0.234 | P-glycoprotein inhibitor | 0.219 0.054 CID_154699659 | ||
| 0.193 | 0.007 | 0.193 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.232 | 0.047 | 0.246 | Nitric-oxide synthase stimulant | 0.246 0.035 CID_154699659 | CID_154699659 | |
| 0.213 | 0.028 | 0.353 | ATPase inhibitor | 0.353 0.004 CID_154699659 | CID_154699659 | |
| 0.254 | 0.07 | 0.413 | Platelet antagonist | 0.413 0.025 CID_154699659 | CID_154699659 | |
| 0.197 | 0.013 | 0.197 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.196 | 0.013 | 0.196 | Vanilloid 1 agonist | 0.179 0.019 CID_154699659 | ||
| 0.201 | 0.019 | 0.201 | Nav1.6 sodium channel blocker | |||
| 0.222 | 0.039 | 0.222 | Protein-tyrosine phosphatase inhibitor | 0.18 0.056 CID_154699659 | ||
| 0.213 | 0.03 | 0.213 | Nav1.2 sodium channel blocker | |||
| 0.204 | 0.023 | 0.204 | Nav1.3 sodium channel blocker | |||
| 0.272 | 0.091 | 0.272 | Streptokinase A inhibitor | |||
| 0.327 | 0.151 | 0.327 | DNA polymerase beta inhibitor | |||
| 0.189 | 0.014 | 0.189 | Alcohol dehydrogenase inhibitor | 0.127 0.03 CID_154699659 | ||
| 0.271 | 0.097 | 0.442 | Interleukin 2 agonist | 0.442 0.017 CID_154699659 | CID_154699659 | |
| 0.206 | 0.032 | 0.206 | Neurotensin receptor agonist | |||
| 0.223 | 0.05 | 0.223 | Dual specificity phosphatase 3 inhibitor | |||
| 0.194 | 0.021 | 0.194 | GABA C receptor agonist | |||
| 0.197 | 0.025 | 0.197 | Chelator | |||
| 0.183 | 0.011 | 0.183 | Estrogen receptor beta antagonist | |||
| 0.193 | 0.024 | 0.193 | Farnesoid X receptor antagonist | |||
| 0.199 | 0.031 | 0.21 | Mannose-6-phosphate isomerase inhibitor | 0.21 0.026 CID_154699659 | CID_154699659 | |
| 0.197 | 0.029 | 0.197 | DNA polymerase I inhibitor | 0.194 0.03 CID_154699659 | ||
| 0.173 | 0.009 | 0.173 | Anabolic | 0.116 0.044 CID_154699659 | ||
| 0.177 | 0.013 | 0.177 | Prolactin inhibitor | |||
| 0.224 | 0.064 | 0.321 | DNA methylase inhibitor | 0.321 0.022 CID_154699659 | CID_154699659 | |
| 0.179 | 0.019 | 0.22 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.22 0.013 CID_154699659 | CID_154699659 | |
| 0.171 | 0.012 | 0.198 | Toll-Like receptor 4 antagonist | 0.198 0.007 CID_154699659 | CID_154699659 | |
| 0.172 | 0.013 | 0.32 | NADH dehydrogenase inhibitor | 0.32 0.006 CID_154699659 | CID_154699659 | |
| 0.195 | 0.036 | 0.195 | Catenin beta inhibitor | |||
| 0.173 | 0.014 | 0.27 | Phosphofructokinase-1 inhibitor | 0.27 0.007 CID_154699659 | CID_154699659 | |
| 0.242 | 0.085 | 0.273 | DNA damaging | 0.273 0.069 CID_154699659 | CID_154699659 | |
| 0.236 | 0.079 | 0.236 | Calpain inhibitor | |||
| 0.179 | 0.022 | 0.179 | Bronchodilator | |||
| 0.198 | 0.042 | 0.291 | Interleukin 6 antagonist | 0.291 0.016 CID_154699659 | CID_154699659 | |
| 0.16 | 0.004 | 0.16 | GABA B receptor agonist | |||
| 0.217 | 0.063 | 0.453 | Platelet adhesion inhibitor | 0.453 0.008 CID_154699659 | CID_154699659 | |
| 0.16 | 0.006 | 0.16 | GABA aminotransferase inhibitor | 0.125 0.014 CID_154699659 | ||
| 0.187 | 0.034 | 0.187 | Neurotrophic factor | 0.149 0.06 CID_154699659 | ||
| 0.243 | 0.092 | 0.243 | Transcription factor STAT inhibitor | |||
| 0.17 | 0.018 | 0.17 | Calcium antagonist | |||
| 0.179 | 0.029 | 0.179 | Antibacterial (Helicobacter pylori) | 0.109 0.1 CID_154699659 | ||
| 0.178 | 0.028 | 0.178 | Adenylate cyclase stimulant | 0.128 0.106 CID_154699659 | ||
| 0.154 | 0.004 | 0.154 | Estrogen-related receptor beta agonist | |||
| 0.154 | 0.005 | 0.255 | Carbonic anhydrase XIV inhibitor | 0.255 0.004 CID_154699659 | CID_154699659 | |
| 0.176 | 0.027 | 0.215 | Microtubule formation inhibitor | 0.215 0.017 CID_154699659 | CID_154699659 | |
| 0.161 | 0.012 | 0.161 | Adrenaline agonist | |||
| 0.176 | 0.028 | 0.176 | Aminopeptidase B inhibitor | |||
| 0.157 | 0.01 | 0.157 | Glutathione S-transferase inhibitor | 0.087 0.051 CID_154699659 | ||
| 0.15 | 0.004 | 0.15 | Nicotinic acid receptor agonist | |||
| 0.206 | 0.06 | 0.206 | Histone acetyltransferase inhibitor | |||
| 0.153 | 0.009 | 0.153 | Acyl-CoA dehydrogenase inhibitor | 0.073 0.025 CID_154699659 | ||
| 0.179 | 0.035 | 0.179 | Protein-tyrosine phosphatase 1B inhibitor | 0.173 0.037 CID_154699659 | ||
| 0.199 | 0.055 | 0.199 | Dual specificity phosphatase inhibitor | |||
| 0.165 | 0.022 | 0.165 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.188 | 0.046 | 0.339 | NOS3 expression enhancer | 0.339 0.013 CID_154699659 | CID_154699659 | |
| 0.162 | 0.02 | 0.162 | Caspase 3 inhibitor | |||
| 0.157 | 0.017 | 0.157 | Electrolyte absorption antagonist | |||
| 0.218 | 0.078 | 0.407 | Peptidyltransferase inhibitor | 0.407 0.006 CID_154699659 | CID_154699659 | |
| 0.192 | 0.054 | 0.192 | Heat shock protein 90 alpha antagonist | |||
| 0.15 | 0.011 | 0.15 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.141 | 0.004 | 0.141 | Squalene epoxidase inhibitor | 0.071 0.013 CID_154699659 | ||
| 0.171 | 0.034 | 0.171 | Interleukin 4 antagonist | 0.152 0.048 CID_154699659 | ||
| 0.153 | 0.018 | 0.153 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.177 | 0.043 | 0.177 | Bone formation stimulant | 0.142 0.066 CID_154699659 | ||
| 0.176 | 0.043 | 0.331 | Cell wall synthesis inhibitor | 0.331 0.008 CID_154699659 | CID_154699659 | |
| 0.14 | 0.008 | 0.14 | Xanthine dehydrogenase inhibitor | 0.05 0.047 CID_154699659 | ||
| 0.189 | 0.057 | 0.189 | Antipruritic | |||
| 0.22 | 0.088 | 0.22 | Neuropeptide Y2 antagonist | |||
| 0.136 | 0.004 | 0.136 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.147 | 0.016 | 0.147 | Glutamate dehydrogenase inhibitor | 0.089 0.037 CID_154699659 | ||
| 0.189 | 0.059 | 0.189 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.227 | 0.098 | 0.227 | Cardiotonic | |||
| 0.134 | 0.005 | 0.134 | Aconitate hydratase inhibitor | |||
| 0.169 | 0.04 | 0.169 | Neuropeptide Y1 antagonist | |||
| 0.138 | 0.009 | 0.138 | Glycine receptor agonist | 0.108 0.017 CID_154699659 | ||
| 0.138 | 0.009 | 0.16 | Neuraminidase (influenza) inhibitor | 0.16 0.006 CID_154699659 | CID_154699659 | |
| 0.178 | 0.051 | 0.322 | Hexokinase inhibitor | 0.322 0.009 CID_154699659 | CID_154699659 | |
| 0.162 | 0.037 | 0.162 | Acetylcholine muscarinic antagonist | |||
| 0.152 | 0.027 | 0.152 | Potassium channel (Ca-activated) activator | |||
| 0.132 | 0.008 | 0.132 | Beta adrenoreceptor antagonist | |||
| 0.169 | 0.045 | 0.169 | Calcium channel blocker | |||
| 0.143 | 0.02 | 0.143 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.192 | 0.07 | 0.433 | Nitric oxide antagonist | 0.433 0.022 CID_154699659 | CID_154699659 | |
| 0.128 | 0.009 | 0.139 | Neuraminidase inhibitor | 0.139 0.007 CID_154699659 | CID_154699659 | |
| 0.132 | 0.013 | 0.132 | Calcium channel L-type blocker | |||
| 0.13 | 0.011 | 0.13 | Carbonic anhydrase VB inhibitor | |||
| 0.124 | 0.007 | 0.124 | Purinergic P2Y antagonist | 0.084 0.012 CID_154699659 | ||
| 0.132 | 0.015 | 0.132 | Phosphodiesterase 5A inhibitor | |||
| 0.175 | 0.059 | 0.175 | Cytidine deaminase inhibitor | |||
| 0.13 | 0.013 | 0.13 | Bile acid receptor antagonist | 0.089 0.077 CID_154699659 | ||
| 0.13 | 0.014 | 0.13 | Argininosuccinate synthase inhibitor | 0.075 0.028 CID_154699659 | ||
| 0.131 | 0.015 | 0.131 | Phosphodiesterase V inhibitor | |||
| 0.138 | 0.023 | 0.138 | Cathepsin G inhibitor | |||
| 0.132 | 0.017 | 0.211 | Phosphodiesterase 6D inhibitor | 0.211 0.004 CID_154699659 | CID_154699659 | |
| 0.127 | 0.012 | 0.127 | Biliverdin reductase inhibitor | 0.072 0.03 CID_154699659 | ||
| 0.143 | 0.028 | 0.37 | Beta glucuronidase inhibitor | 0.37 0.004 CID_154699659 | CID_154699659 | |
| 0.169 | 0.055 | 0.169 | Thiol protease inhibitor | |||
| 0.129 | 0.016 | 0.129 | Estrogen receptor alpha antagonist | |||
| 0.138 | 0.026 | 0.151 | Acetylcholine release stimulant | 0.151 0.016 CID_154699659 | CID_154699659 | |
| 0.125 | 0.013 | 0.125 | Estrogen agonist | 0.072 0.026 CID_154699659 | ||
| 0.121 | 0.011 | 0.121 | Purinergic P2X1 antagonist | 0.057 0.049 CID_154699659 | ||
| 0.124 | 0.014 | 0.124 | Leukotriene antagonist | 0.099 0.022 CID_154699659 | ||
| 0.195 | 0.087 | 0.195 | Interleukin antagonist | |||
| 0.152 | 0.046 | 0.292 | Alkylator | 0.292 0.013 CID_154699659 | CID_154699659 | |
| 0.168 | 0.062 | 0.324 | Diuretic | 0.324 0.019 CID_154699659 | CID_154699659 | |
| 0.112 | 0.008 | 0.112 | Beta 1 adrenoreceptor antagonist | |||
| 0.108 | 0.005 | 0.108 | Glutamate (mGluR group III) antagonist | |||
| 0.135 | 0.032 | 0.141 | Sphingomyelinase inhibitor | 0.141 0.029 CID_154699659 | CID_154699659 | |
| 0.152 | 0.051 | 0.152 | Cholinergic antagonist | |||
| 0.186 | 0.086 | 0.186 | Amyloid beta aggregation inhibitor | 0.135 0.12 CID_154699659 | ||
| 0.2 | 0.1 | 0.2 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.119 | 0.02 | 0.119 | Aminopeptidase I inhibitor | |||
| 0.118 | 0.019 | 0.165 | Glycine receptor antagonist | 0.165 0.005 CID_154699659 | CID_154699659 | |
| 0.138 | 0.039 | 0.138 | Protein kinase C gamma inhibitor | |||
| 0.112 | 0.014 | 0.112 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.087 0.021 CID_154699659 | ||
| 0.27 | 0.173 | 0.27 | Transcription factor inhibitor | |||
| 0.125 | 0.027 | 0.125 | ABCA1 expression enhancer | |||
| 0.114 | 0.017 | 0.114 | D-Ala-D-Ala ligase inhibitor | |||
| 0.15 | 0.054 | 0.15 | NADPH oxidase inhibitor | 0.114 0.091 CID_154699659 | ||
| 0.104 | 0.009 | 0.104 | CD45 antagonist | |||
| 0.101 | 0.006 | 0.324 | Alpha-mannosidase inhibitor | 0.324 0.002 CID_154699659 | CID_154699659 | |
| 0.127 | 0.034 | 0.148 | Uric acid excretion stimulant | 0.148 0.024 CID_154699659 | CID_154699659 | |
| 0.097 | 0.005 | 0.097 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.041 CID_154699659 | ||
| 0.101 | 0.009 | 0.101 | Leukocyte elastase inhibitor | |||
| 0.144 | 0.053 | 0.144 | Acetylcholine antagonist | |||
| 0.096 | 0.005 | 0.096 | Retinoid X receptor agonist | |||
| 0.145 | 0.054 | 0.145 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.108 | 0.017 | 0.108 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.141 | 0.052 | 0.141 | Adenylate cyclase inhibitor | |||
| 0.111 | 0.024 | 0.111 | Carbonic anhydrase V inhibitor | |||
| 0.096 | 0.009 | 0.096 | Sphingosine kinase 2 inhibitor | |||
| 0.091 | 0.005 | 0.091 | Glutamate (mGluR3) antagonist | |||
| 0.109 | 0.024 | 0.109 | Peroxisome proliferator-activated receptor gamma agonist | 0.076 0.043 CID_154699659 | ||
| 0.151 | 0.067 | 0.461 | Hemostatic | 0.461 0.005 CID_154699659 | CID_154699659 | |
| 0.113 | 0.029 | 0.192 | Transcription factor NF kappa B stimulant | 0.192 0.01 CID_154699659 | CID_154699659 | |
| 0.107 | 0.023 | 0.107 | Adenosine A3 receptor antagonist | |||
| 0.127 | 0.044 | 0.127 | Nav1.1 sodium channel blocker | |||
| 0.112 | 0.029 | 0.112 | Interleukin 5 antagonist | 0.102 0.039 CID_154699659 | ||
| 0.298 | 0.216 | 0.298 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.092 | 0.01 | 0.092 | Sphingosine kinase inhibitor | |||
| 0.138 | 0.056 | 0.138 | Cathepsin H inhibitor | |||
| 0.098 | 0.017 | 0.098 | CDC25B inhibitor | |||
| 0.088 | 0.007 | 0.307 | Mannosidase inhibitor | 0.307 0.002 CID_154699659 | CID_154699659 | |
| 0.086 | 0.006 | 0.086 | Leukotriene C antagonist | 0.053 0.049 CID_154699659 | ||
| 0.09 | 0.009 | 0.09 | Beta 2 adrenoreceptor antagonist | |||
| 0.1 | 0.02 | 0.1 | Elastase 1 inhibitor | |||
| 0.087 | 0.007 | 0.087 | Dihydroorotase inhibitor | |||
| 0.096 | 0.016 | 0.096 | Androgen agonist | |||
| 0.105 | 0.025 | 0.161 | Interferon agonist | 0.161 0.009 CID_154699659 | CID_154699659 | |
| 0.086 | 0.007 | 0.086 | Glutamate (mGluR1a) antagonist | |||
| 0.103 | 0.024 | 0.103 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.104 | 0.025 | 0.104 | CDC25A inhibitor | |||
| 0.095 | 0.017 | 0.095 | MAP kinase kinase 7 inhibitor | |||
| 0.091 | 0.013 | 0.091 | Estrogen receptor beta agonist | |||
| 0.127 | 0.05 | 0.127 | GABA receptor agonist | |||
| 0.12 | 0.043 | 0.12 | Gastric antisecretory | |||
| 0.151 | 0.074 | 0.151 | Heat shock protein 90 antagonist | |||
| 0.082 | 0.006 | 0.082 | GABA B receptor antagonist | |||
| 0.177 | 0.1 | 0.177 | Platelet aggregation inhibitor | 0.151 0.127 CID_154699659 | ||
| 0.101 | 0.025 | 0.101 | Leukotriene synthesis inhibitor | |||
| 0.089 | 0.013 | 0.118 | Leukotriene B4 antagonist | 0.118 0.007 CID_154699659 | CID_154699659 | |
| 0.158 | 0.082 | 0.158 | Mcl-1 antagonist | |||
| 0.09 | 0.015 | 0.09 | Toll-Like receptor 2 agonist | 0.076 0.017 CID_154699659 | ||
| 0.096 | 0.022 | 0.096 | Carbamoyl phosphate synthetase inhibitor | 0.056 0.047 CID_154699659 | ||
| 0.089 | 0.015 | 0.098 | Nitric oxide donor | 0.098 0.01 CID_154699659 | CID_154699659 | |
| 0.145 | 0.071 | 0.145 | MAP kinase kinase 4 inhibitor | |||
| 0.226 | 0.151 | 0.226 | Thioredoxin glutathione reductase inhibitor | |||
| 0.081 | 0.007 | 0.081 | Retinoid X alpha receptor agonist | |||
| 0.091 | 0.017 | 0.091 | Beta 3 adrenoreceptor antagonist | |||
| 0.088 | 0.015 | 0.088 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.079 | 0.006 | 0.079 | Dopamine D5 agonist | |||
| 0.081 | 0.009 | 0.081 | Adenosine deaminase inhibitor | 0.077 0.01 CID_154699659 | ||
| 0.093 | 0.02 | 0.093 | Acetylcholine M3 receptor antagonist | |||
| 0.086 | 0.014 | 0.086 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.092 | 0.021 | 0.092 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.082 | 0.012 | 0.082 | Potassium channel Kv1.3 blocker | |||
| 0.094 | 0.024 | 0.114 | Phosphodiesterase VI inhibitor | 0.114 0.014 CID_154699659 | CID_154699659 | |
| 0.109 | 0.038 | 0.109 | Histamine N-methyltransferase inhibitor | |||
| 0.078 | 0.008 | 0.078 | Pregnane X receptor antagonist | |||
| 0.079 | 0.009 | 0.082 | Adenine nucleotide translocase inhibitor | 0.082 0.008 CID_154699659 | CID_154699659 | |
| 0.084 | 0.015 | 0.084 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.074 | 0.004 | 0.074 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.159 | 0.09 | 0.159 | Tumour necrosis factor antagonist | |||
| 0.078 | 0.009 | 0.118 | Glucose-6-phosphate isomerase inhibitor | 0.118 0.004 CID_154699659 | CID_154699659 | |
| 0.084 | 0.016 | 0.084 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.113 | 0.044 | 0.113 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.084 | 0.017 | 0.084 | Phosphodiesterase 1C inhibitor | |||
| 0.075 | 0.007 | 0.075 | Dihydropteroate synthase inhibitor | |||
| 0.086 | 0.019 | 0.123 | Interferon inducer | 0.123 0.007 CID_154699659 | CID_154699659 | |
| 0.094 | 0.028 | 0.094 | Carbonic anhydrase VA inhibitor | |||
| 0.108 | 0.042 | 0.108 | NMDA receptor antagonist | |||
| 0.098 | 0.033 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.124 0.014 CID_154699659 | CID_154699659 | |
| 0.107 | 0.043 | 0.129 | Interleukin 12 antagonist | 0.129 0.022 CID_154699659 | CID_154699659 | |
| 0.077 | 0.012 | 0.077 | Estrogen receptor alpha agonist | |||
| 0.078 | 0.013 | 0.078 | Carbonic anhydrase VII inhibitor | |||
| 0.179 | 0.115 | 0.267 | Antiamyloidogenic | 0.267 0.064 CID_154699659 | CID_154699659 | |
| 0.083 | 0.019 | 0.083 | Transcription factor AP-1 inhibitor | 0.079 0.022 CID_154699659 | ||
| 0.072 | 0.009 | 0.072 | Cholesterol esterase inhibitor | |||
| 0.076 | 0.014 | 0.076 | Thromboxane synthase inhibitor | |||
| 0.146 | 0.085 | 0.354 | Thrombolytic | 0.354 0.016 CID_154699659 | CID_154699659 | |
| 0.075 | 0.013 | 0.075 | Beta 2 adrenoreceptor agonist | |||
| 0.067 | 0.006 | 0.067 | Beta adrenoreceptor agonist | |||
| 0.196 | 0.136 | 0.196 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.103 | 0.045 | 0.138 | Thioredoxin inhibitor | 0.138 0.021 CID_154699659 | CID_154699659 | |
| 0.063 | 0.005 | 0.063 | Retinoid X receptor antagonist | |||
| 0.079 | 0.022 | 0.079 | Ornithine carbamoyltransferase inhibitor | 0.048 0.042 CID_154699659 | ||
| 0.081 | 0.024 | 0.081 | Maillard reaction inhibitor | |||
| 0.087 | 0.03 | 0.087 | Potassium channel large-conductance Ca-activated activator | |||
| 0.061 | 0.005 | 0.078 | Uridine phosphorylase inhibitor | 0.078 0.004 CID_154699659 | CID_154699659 | |
| 0.064 | 0.008 | 0.064 | Retinoic acid alpha receptor agonist | 0.038 0.03 CID_154699659 | ||
| 0.063 | 0.008 | 0.063 | Prostaglandin agonist | |||
| 0.07 | 0.016 | 0.07 | Oleamide hydrolase inhibitor | |||
| 0.094 | 0.041 | 0.094 | Vanilloid agonist | |||
| 0.076 | 0.023 | 0.076 | Thromboxane antagonist | |||
| 0.058 | 0.006 | 0.058 | Leukotriene C4 antagonist | |||
| 0.061 | 0.009 | 0.061 | GABA uptake inhibitor | |||
| 0.063 | 0.011 | 0.072 | Neuraminidase (Influenza A) inhibitor | 0.072 0.007 CID_154699659 | CID_154699659 | |
| 0.059 | 0.007 | 0.059 | Angiotensin AT1 receptor antagonist | |||
| 0.08 | 0.029 | 0.08 | Acetylcholine M2 receptor antagonist | |||
| 0.08 | 0.03 | 0.08 | Protein kinase C beta inhibitor | |||
| 0.059 | 0.01 | 0.059 | Farnesoid X receptor agonist | |||
| 0.053 | 0.004 | 0.053 | Glutamate (mGluR3) agonist | |||
| 0.07 | 0.022 | 0.07 | Glucosylceramidase inhibitor | 0.064 0.027 CID_154699659 | ||
| 0.072 | 0.024 | 0.072 | Fatty acid synthase inhibitor | |||
| 0.056 | 0.007 | 0.056 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.067 | 0.019 | 0.067 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.053 | 0.005 | 0.053 | Retinoid X alpha receptor antagonist | |||
| 0.126 | 0.079 | 0.126 | Alkaline phosphatase inhibitor | 0.125 0.08 CID_154699659 | ||
| 0.069 | 0.022 | 0.069 | Thromboxane A2 antagonist | |||
| 0.107 | 0.062 | 0.309 | AMP-activated protein kinase stimulant | 0.309 0.005 CID_154699659 | CID_154699659 | |
| 0.05 | 0.005 | 0.05 | Retinoic acid receptor agonist | 0.024 0.014 CID_154699659 | ||
| 0.051 | 0.006 | 0.051 | Angiotensin II receptor antagonist | |||
| 0.279 | 0.236 | 0.76 | Antiinflammatory | 0.76 0.021 CID_154699659 | CID_154699659 | |
| 0.089 | 0.047 | 0.184 | Topoisomerase II alpha inhibitor | 0.184 0.017 CID_154699659 | CID_154699659 | |
| 0.072 | 0.029 | 0.072 | Acetylcholine M5 receptor antagonist | |||
| 0.062 | 0.02 | 0.228 | Heparanase inhibitor | 0.228 0.002 CID_154699659 | CID_154699659 | |
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR4) antagonist | |||
| 0.05 | 0.008 | 0.05 | Liver X receptor beta antagonist | |||
| 0.065 | 0.023 | 0.065 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.087 | 0.046 | 0.087 | Caspase 7 inhibitor | |||
| 0.119 | 0.078 | 0.119 | M17 leucyl aminopeptidase inhibitor | |||
| 0.046 | 0.005 | 0.046 | Glutamate (mGluR1) agonist | |||
| 0.098 | 0.057 | 0.098 | Breast cancer-resistant protein inhibitor | |||
| 0.11 | 0.07 | 0.11 | Calcium channel (voltage-sensitive) blocker | |||
| 0.138 | 0.098 | 0.138 | Growth hormone agonist | |||
| 0.051 | 0.011 | 0.051 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.052 | 0.012 | 0.052 | RNA-directed RNA polymerase inhibitor | |||
| 0.044 | 0.004 | 0.044 | Estrogen-related receptor gamma antagonist | |||
| 0.063 | 0.024 | 0.063 | Dihydroorotate oxidase inhibitor | |||
| 0.121 | 0.083 | 0.121 | Toll-Like receptor antagonist | |||
| 0.112 | 0.074 | 0.112 | Interleukin 8 antagonist | |||
| 0.046 | 0.009 | 0.046 | ATP citrate lysase inhibitor | |||
| 0.049 | 0.012 | 0.049 | Glutamate (mGluR8) agonist | |||
| 0.171 | 0.134 | 0.171 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.074 | 0.037 | 0.074 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.044 | 0.007 | 0.044 | Prostaglandin EP2 agonist | |||
| 0.073 | 0.037 | 0.073 | Glutamate (mGluR7) antagonist | |||
| 0.081 | 0.045 | 0.081 | Acetylcholine M4 receptor antagonist | |||
| 0.061 | 0.025 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.068 | 0.033 | 0.068 | Calcium channel P-type blocker | |||
| 0.043 | 0.009 | 0.043 | Estrogen-related receptor beta antagonist | |||
| 0.048 | 0.015 | 0.048 | Nicotinic acid receptor 2 agonist | |||
| 0.042 | 0.008 | 0.042 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.119 | 0.085 | 0.119 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.038 | 0.005 | 0.06 | Vanilloid 2 agonist | 0.06 0.002 CID_154699659 | CID_154699659 | |
| 0.048 | 0.016 | 0.048 | Kainate receptor agonist | |||
| 0.072 | 0.039 | 0.072 | Exportin-1 inhibitor | |||
| 0.089 | 0.056 | 0.089 | Androgen antagonist | |||
| 0.038 | 0.006 | 0.038 | Prostaglandin F2 alpha agonist | |||
| 0.063 | 0.031 | 0.075 | Lipocortins synthesis agonist | 0.075 0.017 CID_154699659 | CID_154699659 | |
| 0.061 | 0.029 | 0.061 | NMDA 2A receptor antagonist | |||
| 0.053 | 0.022 | 0.053 | Oxytocin agonist | |||
| 0.086 | 0.055 | 0.086 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.035 | 0.005 | 0.035 | Retinoic acid beta receptor agonist | |||
| 0.05 | 0.019 | 0.05 | Liver X receptor alpha agonist | |||
| 0.034 | 0.004 | 0.034 | Neuraminidase (Influenza B) inhibitor | 0.02 0.017 CID_154699659 | ||
| 0.062 | 0.032 | 0.062 | Ryanodine receptor antagonist | |||
| 0.049 | 0.019 | 0.049 | 5-Alpha-reductase inhibitor | |||
| 0.053 | 0.023 | 0.085 | Cytokine production stimulant | 0.085 0.005 CID_154699659 | CID_154699659 | |
| 0.043 | 0.013 | 0.043 | HCV NS5B polymerase inhibitor | |||
| 0.052 | 0.023 | 0.052 | Benzodiazepine antagonist | |||
| 0.089 | 0.06 | 0.089 | Phosphodiesterase I inhibitor | |||
| 0.036 | 0.007 | 0.036 | Nicotinic acid receptor 2 antagonist | |||
| 0.082 | 0.052 | 0.082 | Acetylcholine nicotinic antagonist | |||
| 0.049 | 0.02 | 0.049 | NMDA receptor subunit 3A antagonist | |||
| 0.05 | 0.021 | 0.054 | Guanylate cyclase inhibitor | 0.054 0.017 CID_154699659 | CID_154699659 | |
| 0.06 | 0.032 | 0.06 | GABA receptor antagonist | |||
| 0.046 | 0.017 | 0.046 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.036 | 0.008 | 0.036 | Prostaglandin E2 agonist | |||
| 0.067 | 0.039 | 0.067 | NMDA receptor agonist | |||
| 0.063 | 0.036 | 0.063 | Glutamate (mGluR1) antagonist | |||
| 0.065 | 0.037 | 0.065 | TRPA1 antagonist | |||
| 0.069 | 0.042 | 0.069 | MDM2 inhibitor | |||
| 0.075 | 0.048 | 0.075 | Lipase inhibitor | |||
| 0.066 | 0.039 | 0.066 | NMDA receptor glycine site agonist | |||
| 0.062 | 0.035 | 0.062 | Botulinum neurotoxin type A inhibitor | |||
| 0.045 | 0.018 | 0.045 | Calcitonin receptor agonist | |||
| 0.103 | 0.076 | 0.103 | Electron transport complex I inhibitor | |||
| 0.107 | 0.081 | 0.107 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.118 | 0.092 | 0.118 | Cytokine production inhibitor | |||
| 0.106 | 0.08 | 0.106 | Proteasome inhibitor | |||
| 0.048 | 0.023 | 0.048 | Kainate receptor antagonist | |||
| 0.055 | 0.03 | 0.055 | Vanilloid 2 antagonist | |||
| 0.126 | 0.102 | 0.126 | MAP3K9 inhibitor | |||
| 0.066 | 0.042 | 0.066 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.029 | 0.005 | 0.029 | Retinoid X beta receptor antagonist | |||
| 0.063 | 0.039 | 0.063 | Phosphodiesterase 1B inhibitor | |||
| 0.041 | 0.018 | 0.041 | Fumarate hydratase inhibitor | |||
| 0.032 | 0.009 | 0.032 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.063 | 0.04 | 0.063 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.03 | 0.007 | 0.03 | Retinoic acid gamma receptor agonist | |||
| 0.058 | 0.035 | 0.058 | Protein kinase C eta inhibitor | |||
| 0.029 | 0.006 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 CID_154699659 | ||
| 0.039 | 0.017 | 0.039 | Free fatty acid receptor 1 antagonist | |||
| 0.058 | 0.035 | 0.058 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.03 | 0.008 | 0.03 | Beta 1 adrenoreceptor agonist | |||
| 0.059 | 0.037 | 0.059 | Ribonucleotide reductase inhibitor | |||
| 0.035 | 0.013 | 0.035 | Elastase 2B inhibitor | |||
| 0.035 | 0.013 | 0.035 | Elastase 3B inhibitor | |||
| 0.035 | 0.013 | 0.035 | Elastase 3A inhibitor | |||
| 0.104 | 0.082 | 0.237 | Topoisomerase II inhibitor | 0.237 0.026 CID_154699659 | CID_154699659 | |
| 0.058 | 0.037 | 0.077 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.077 0.022 CID_154699659 | CID_154699659 | |
| 0.026 | 0.005 | 0.026 | Estrogen-related receptor gamma agonist | |||
| 0.094 | 0.074 | 0.094 | Urease inhibitor | |||
| 0.081 | 0.061 | 0.081 | GABA A receptor agonist | |||
| 0.088 | 0.069 | 0.088 | Protein kinase C zeta inhibitor | |||
| 0.06 | 0.041 | 0.06 | Phosphodiesterase 1A inhibitor | |||
| 0.055 | 0.035 | 0.055 | GABA A receptor antagonist | |||
| 0.038 | 0.019 | 0.038 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.027 | 0.008 | 0.027 | Prostaglandin EP4 agonist | |||
| 0.038 | 0.019 | 0.038 | Estrogen-related receptor alpha antagonist | |||
| 0.03 | 0.012 | 0.03 | Thyroid hormone agonist | |||
| 0.037 | 0.019 | 0.037 | Sirtuin 2 inhibitor | |||
| 0.024 | 0.006 | 0.024 | Carbonic anhydrase X inhibitor | |||
| 0.024 | 0.006 | 0.024 | Carbonic anhydrase VIII inhibitor | |||
| 0.03 | 0.013 | 0.03 | Retinoid X gamma receptor antagonist | |||
| 0.068 | 0.051 | 0.068 | Amidase inhibitor | |||
| 0.026 | 0.009 | 0.026 | Retinoic acid alpha receptor antagonist | |||
| 0.058 | 0.04 | 0.058 | Dopamine uptake inhibitor | |||
| 0.064 | 0.047 | 0.393 | Selectin antagonist | 0.393 0.003 CID_154699659 | CID_154699659 | |
| 0.026 | 0.009 | 0.026 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.024 | 0.008 | 0.024 | Retinoic acid receptor antagonist | |||
| 0.08 | 0.064 | 0.08 | CC chemokine 5 receptor agonist | |||
| 0.046 | 0.03 | 0.046 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.028 | 0.012 | 0.028 | Retinoid X gamma receptor agonist | |||
| 0.026 | 0.01 | 0.026 | Retinoid X beta receptor agonist | |||
| 0.028 | 0.013 | 0.138 | Sodium/glucose cotransporter inhibitor | 0.138 0.002 CID_154699659 | CID_154699659 | |
| 0.028 | 0.012 | 0.028 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.026 | 0.011 | 0.026 | Phosphodiesterase 6A inhibitor | |||
| 0.028 | 0.013 | 0.028 | Purinergic P2Y12 antagonist | 0.022 0.017 CID_154699659 | ||
| 0.038 | 0.024 | 0.064 | Arginase inhibitor | 0.064 0.009 CID_154699659 | CID_154699659 | |
| 0.069 | 0.055 | 0.069 | Epoxide hydrolase inhibitor | |||
| 0.051 | 0.036 | 0.051 | CXC chemokine 1 receptor antagonist | |||
| 0.056 | 0.042 | 0.056 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.021 | 0.008 | 0.021 | Nicotinic acid receptor 1 antagonist | |||
| 0.048 | 0.034 | 0.048 | Dopamine beta hydroxylase inhibitor | |||
| 0.033 | 0.02 | 0.033 | Cholesterol ester transfer protein antagonist | |||
| 0.102 | 0.088 | 0.102 | MAO inhibitor | |||
| 0.038 | 0.025 | 0.038 | Delayed rectifier potassium channel blocker | |||
| 0.019 | 0.006 | 0.019 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.054 | 0.041 | 0.054 | Immunoglobulin Fc receptor antagonist | |||
| 0.057 | 0.044 | 0.065 | Prostaglandin EP2 antagonist | 0.065 0.037 CID_154699659 | CID_154699659 | |
| 0.034 | 0.022 | 0.034 | Liver X receptor beta agonist | |||
| 0.028 | 0.016 | 0.125 | Sodium/glucose cotransporter 2 inhibitor | 0.125 0.002 CID_154699659 | CID_154699659 | |
| 0.043 | 0.031 | 0.043 | NMDA receptor subunit 3B antagonist | |||
| 0.034 | 0.023 | 0.034 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.079 | 0.068 | 0.079 | Myeloperoxidase inhibitor | |||
| 0.083 | 0.072 | 0.083 | MAO B inhibitor | |||
| 0.02 | 0.009 | 0.06 | Ileal bile acid transport inhibitor | 0.06 0.003 CID_154699659 | CID_154699659 | |
| 0.033 | 0.023 | 0.033 | Catechol O-methyltransferase inhibitor | |||
| 0.04 | 0.031 | 0.04 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.038 | 0.029 | 0.038 | Membrane dipeptidase inhibitor | |||
| 0.033 | 0.024 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.033 | 0.024 | 0.033 | Protein kinase C beta I inhibitor | |||
| 0.021 | 0.012 | 0.021 | Caspase 8 inhibitor | |||
| 0.019 | 0.01 | 0.019 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.07 | 0.061 | 0.07 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.02 | 0.011 | 0.034 | Antibiotic Anthracycline-like | 0.034 0.003 CID_154699659 | CID_154699659 | |
| 0.016 | 0.008 | 0.016 | Angiotensin AT1B receptor antagonist | |||
| 0.088 | 0.081 | 0.232 | Topoisomerase I inhibitor | 0.232 0.02 CID_154699659 | CID_154699659 | |
| 0.065 | 0.057 | 0.065 | HIV-1 integrase inhibitor | |||
| 0.053 | 0.046 | 0.053 | Adenosine A1 receptor antagonist | |||
| 0.056 | 0.049 | 0.056 | Carbonic anhydrase inhibitor | 0.054 0.052 CID_154699659 | ||
| 0.027 | 0.02 | 0.027 | Hedgehog signaling activator | |||
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | 0.016 0.012 CID_154699659 | ||
| 0.236 | 0.229 | 0.775 | Cyclophilin D inhibitor | 0.775 0.008 CID_154699659 | CID_154699659 | |
| 0.083 | 0.077 | 0.083 | MAO A inhibitor | |||
| 0.049 | 0.043 | 0.049 | Elastase inhibitor | |||
| 0.034 | 0.028 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 CID_154699659 | CID_154699659 | |
| 0.012 | 0.007 | 0.012 | Retinoic acid receptor gamma antagonist | |||
| 0.019 | 0.014 | 0.019 | 5-Alpha-reductase 2 inhibitor | |||
| 0.039 | 0.034 | 0.039 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.039 | 0.034 | 0.039 | Sphingosine kinase 1 inhibitor | |||
| 0.081 | 0.076 | 0.129 | ATPase (Vacuolar H+) inhibitor | 0.129 0.014 CID_154699659 | CID_154699659 | |
| 0.032 | 0.027 | 0.032 | Carnitine palmitoyltransferase inhibitor | |||
| 0.041 | 0.036 | 0.041 | Sphingosine 1-phosphate receptor agonist | |||
| 0.036 | 0.032 | 0.036 | Vanilloid 3 antagonist | |||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.054 | 0.051 | 0.054 | Heat shock protein 90 beta antagonist | |||
| 0.011 | 0.008 | 0.011 | Beta 3 adrenoreceptor agonist | |||
| 0.047 | 0.044 | 0.054 | Factor III inhibitor | 0.054 0.025 CID_154699659 | CID_154699659 | |
| 0.04 | 0.037 | 0.129 | Phosphorylase inhibitor | 0.129 0.009 CID_154699659 | CID_154699659 | |
| 0.025 | 0.022 | 0.025 | Leukotriene B4 receptor 1 antagonist | |||
| 0.032 | 0.029 | 0.032 | Phosphoglycerate kinase inhibitor | |||
| 0.038 | 0.035 | 0.038 | CF transmembrane conductance regulator antagonist | |||
| 0.012 | 0.009 | 0.012 | Retinoic acid beta receptor antagonist | |||
| 0.016 | 0.014 | 0.025 | Telomerase stimulant | 0.025 0.004 CID_154699659 | CID_154699659 | |
| 0.03 | 0.028 | 0.03 | Protein kinase C beta II inhibitor | |||
| 0.047 | 0.046 | 0.099 | Glucose-6-phosphate translocase inhibitor | 0.099 0.006 CID_154699659 | CID_154699659 | |
| 0.039 | 0.038 | 0.039 | Geranyltranstransferase inhibitor | |||
| 0.027 | 0.027 | 0.061 | Squalene synthetase inhibitor | 0.061 0.011 CID_154699659 | CID_154699659 | |
| 0.115 | 0.12 | 0.291 | Insulin secretagoues | 0.291 0.013 CID_154699659 | CID_154699659 | |
| 0.018 | 0.023 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 CID_154699659 | CID_154699659 | |
| 0.025 | 0.031 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 CID_154699659 | CID_154699659 | |
| 0.104 | 0.116 | 0.198 | DNA repair enzyme inhibitor | 0.198 0.009 CID_154699659 | CID_154699659 | |
| 0.036 | 0.049 | 0.078 | Carbonic anhydrase XII inhibitor | 0.078 0.026 CID_154699659 | CID_154699659 | |
| 0.038 | 0.055 | 0.071 | Aldose reductase inhibitor | 0.071 0.027 CID_154699659 | CID_154699659 | |
| 0.035 | 0.053 | 0.054 | Microtubule stabilization | 0.054 0.023 CID_154699659 | CID_154699659 | |
| 0.014 | 0.034 | 0.021 | Corticosteroid-like | 0.021 0.015 CID_154699659 | CID_154699659 | |
| 0.032 | 0.059 | 0.051 | Carbonic anhydrase IX inhibitor | 0.051 0.042 CID_154699659 | CID_154699659 | |
| 0.006 | 0.04 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 CID_154699659 | CID_154699659 | |
| 0.138 | 0.176 | 0.439 | Tumour necrosis factor alpha release inhibitor | 0.439 0.021 CID_154699659 | CID_154699659 | |
| 0.086 | 0.127 | 0.321 | Cell adhesion inhibitor | 0.321 0.009 CID_154699659 | CID_154699659 | |
| 0.079 | 0.124 | 0.113 | Multidrug resistance-associated protein 1 inhibitor | 0.113 0.057 CID_154699659 | CID_154699659 | |
| 0.047 | 0.102 | 0.097 | Histone deacetylase stimulant | 0.097 0.029 CID_154699659 | CID_154699659 | |
| 0.047 | 0.102 | 0.097 | Histone deacetylase SIRT1 stimulant | 0.097 0.029 CID_154699659 | CID_154699659 | |
| 0.04 | 0.099 | 0.202 | Antineoplastic antibiotic | 0.202 0.021 CID_154699659 | CID_154699659 | |
| 0.011 | 0.072 | 0.023 | Dopamine D1 agonist | 0.023 0.016 CID_154699659 | CID_154699659 | |
| 0.023 | 0.085 | 0.08 | Antibiotic Aminoglycoside-like | 0.08 0.004 CID_154699659 | CID_154699659 | |
| 0.018 | 0.09 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 CID_154699659 | CID_154699659 | |
| 0.002 | 0.077 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 CID_154699659 | CID_154699659 | |
| 0.012 | 0.094 | 0.059 | Protein 30S ribosomal subunit inhibitor | 0.059 0.006 CID_154699659 | CID_154699659 | |
| 0.109 | 0.193 | 0.144 | CC chemokine 6 receptor antagonist | 0.144 0.032 CID_154699659 | CID_154699659 | |
| 0.051 | 0.147 | 0.163 | Cell adhesion molecule inhibitor | 0.163 0.013 CID_154699659 | CID_154699659 | |
| 0.022 | 0.135 | 0.107 | Protein 50S ribosomal subunit inhibitor | 0.107 0.011 CID_154699659 | CID_154699659 | |
| 0.007 | 0.135 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 CID_154699659 | CID_154699659 | |
| 0.026 | 0.181 | 0.095 | Factor IXa inhibitor | 0.095 0.011 CID_154699659 | CID_154699659 | |
| 0.124 | 0.295 | 0.487 | Immunomodulator | 0.487 0.025 CID_154699659 | CID_154699659 | |
| 0.038 | 0.227 | 0.116 | DNA intercalator | 0.116 0.06 CID_154699659 | CID_154699659 | |
| 0.043 | 0.338 | 0.238 | Anticoagulant | 0.238 0.041 CID_154699659 | CID_154699659 | |
| 0.044 | 0.392 | 0.085 | T cell inhibitor | 0.085 0.05 CID_154699659 | CID_154699659 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |